LANSING, Mich. — Senate Health Policy and Human Services Chairman Curt VanderWall on Wednesday introduced two resolutions calling on the governor and executive branch to reduce the costs of insulin by purchasing generic insulin in bulk or by manufacturing insulin in Michigan.
“More than a million Michiganders are reported to be living with diabetes — and for the 5 to 10% of people living with type 1 diabetes, daily access to insulin is crucial for their health and survival,” said VanderWall, R-Ludington. “Historic inflation across many sectors of our economy continue to have many families across our state struggling to make ends meet coupled with the ever-increasing costs of insulin are putting vulnerable people’s lives in danger. The state has the resources to help alleviate this burden and executive offices must work in earnest to help find relief.”
Senate Resolution 170, adopted Wednesday by the Senate, and Senate Concurrent Resolution 29 urge the governor, Michigan Department of Health and Human Services, Department of Insurance and Financial Services, Department of Licensing and Regulatory Affairs, Michigan Economic Development Corporation, and other executive departments to take action to make insulin more accessible and affordable.
“All insulin users, including those with both public or private insurance plans, deserve affordable and accessible life-saving insulin,” VanderWall said. “To provide that access, the state needs to further investigate how we can use public and private partnerships to acquire insulin in bulk at lower prices or produce insulin right here in Michigan. This investigation should include the development of a strategic plan on how the state can manufacture and distribute insulin.”